The Urology Company appointed to sell Multi-Gyn in the UK

The Urology Company will act as the UK exclusive distributor and will retain the product names and rebrand the products to their international identities: Multi-Gyn®. The Urology Company intends to roll out the entire product range in the United Kingdom and ensure a national retail distribution.

Recently, the Urology Company has significantly strengthened its UK sales and marketing infrastructure and indicated that it intends to expand its product portfolio to exploit this resource. The Urology Company intends to expand the UK retail distribution of the BioClin products through listings in a number of major UK retail pharmacies, and healthcare chains. The Urology Company believes that the Multi-Gyn® products are highly complementary to its existing Hyalofemme and hI-Cran products.

Bill Robinson, Chairman, Plethora said:
“For our investors, this agreement demonstrates our ability to secure products with existing revenues to add to our portfolio and leverage the infrastructure we have established. For our customers and patients these products will help treat often distressing conditions with highly effective products.”

Floris Koumans, Chairman, BioClin said:
“We chose to work with The Urology Company as we recognize its leadership position as the UK‟s urology and sexual health expert. Our products are highly effective and having the specialist skills that our new partner can deliver will ensure that women in the UK get the treatments they need.”